19 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Analysis of HIF-1 inhibition by manassantin A and analogues with modified tetrahydrofuran configurations.
Duke University
Synthesis and evaluation of cyclopentane-based muraymycin analogs targeting MraY.
Duke University
Inhibition of the antibacterial target UDP-(3-O-acyl)-N-acetylglucosamine deacetylase (LpxC): isoxazoline zinc amidase inhibitors bearing diverse metal binding groups.
Duke University
Structure-Functional-Selectivity Relationship Studies of Novel Apomorphine Analogs to Develop D1R/D2R Biased Ligands.
Duke University
Synthesis and Biological Evaluation of Manassantin Analogues for Hypoxia-Inducible Factor 1α Inhibition.
Duke University
Synthesis, structure, and antibiotic activity of aryl-substituted LpxC inhibitors.
Duke University
Synthesis and biological evaluation of largazole zinc-binding group analogs.
Duke University
Pyrazolopyrimidine compound and preparation method therefor and use thereof in preparation of anti-cancer drug
Suzhou Raymon Pharmaceuticals Company
LYSINE ACETYLTRANSFERASE 6A (KAT6A) INHIBITORS AND USES THEREOF
Insilico Medicine Ip
Selective histone deactylase 6 inhibitors
H. Lee Moffitt Cancer Center and Research Institute
Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the difference.
Universita Degli Studi Di Firenze
Synthesis of bivalent beta2-adrenergic and adenosine A1 receptor ligands.
Monash University
Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection.
Merck Research Laboratories